Management of Diabetes Mellitus Patients With Retinopathy
1 other identifier
observational
2,500
1 country
62
Brief Summary
Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:
- which medication are used to keep blood pressure under control?
- which medication are used for metabolic control?
- the average control level of metabolism and blood pressure is compliant with the international guidelines?
- laser photocoagulation plays a role in the control of metabolism and blood pressure?
- there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?
- there is an influence of renal failure on the choose of medication?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2008
Shorter than P25 for all trials
62 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 23, 2009
CompletedFirst Posted
Study publicly available on registry
January 26, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedAugust 18, 2010
August 1, 2010
January 23, 2009
August 17, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight
every 3 months
evolution of diabetic retinopathy
every 3 months
Secondary Outcomes (1)
concomitant medication
every 3 months
Study Arms (1)
1
Diabetic patients with retinopathy
Eligibility Criteria
Diabetic patients with diabetic retinopathy
You may qualify if:
- Diabetic patients
- Diabetic retinopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (62)
Research Site
Diegten, Basel-Landschaft, Switzerland
Research Site
Laufen, Basel-Landschaft, Switzerland
Research Site
Dättwil, Canton of Aargau, Switzerland
Research Site
Hausen B. Brugg, Canton of Aargau, Switzerland
Research Site
Lenzburg, Canton of Aargau, Switzerland
Research Site
Lupfig, Canton of Aargau, Switzerland
Research Site
Muri, Canton of Aargau, Switzerland
Research Site
Rheinfelden, Canton of Aargau, Switzerland
Research Site
Schinznach Dorf, Canton of Aargau, Switzerland
Research Site
Spreitenbach, Canton of Aargau, Switzerland
Research Site
Basel, Canton of Basel-City, Switzerland
Research Site
Bern, Canton of Bern, Switzerland
Research Site
Moutier, Canton of Bern, Switzerland
Research Site
Unterseen, Canton of Bern, Switzerland
Research Site
Estavayer-le-Lac, Canton of Fribourg, Switzerland
Research Site
Fribourg, Canton of Fribourg, Switzerland
Research Site
Collonge-Bellerive, Canton of Geneva, Switzerland
Research Site
Geneva, Canton of Geneva, Switzerland
Research Site
Le Grand-Saconnex, Canton of Geneva, Switzerland
Research Site
Les Acacias, Canton of Geneva, Switzerland
Research Site
Versoix, Canton of Geneva, Switzerland
Research Site
Alle, Canton of Jura, Switzerland
Research Site
Lucerne, Canton of Lucerne, Switzerland
Research Site
Rothenburg, Canton of Lucerne, Switzerland
Research Site
Le Locle, Canton of Neuchâtel, Switzerland
Research Site
Kerns, Canton of Obwalden, Switzerland
Research Site
Schaffhausen, Canton of Schaffhausen, Switzerland
Research Site
Küssnacht, Canton of Schwyz, Switzerland
Research Site
Tuggen, Canton of Schwyz, Switzerland
Research Site
Oberuzwil, Canton of St. Gallen, Switzerland
Research Site
Rorschach, Canton of St. Gallen, Switzerland
Research Site
Sankt Gallen, Canton of St. Gallen, Switzerland
Research Site
Wangs, Canton of St. Gallen, Switzerland
Research Site
Aigle, Canton of Vaud, Switzerland
Research Site
Bassins, Canton of Vaud, Switzerland
Research Site
Bex, Canton of Vaud, Switzerland
Research Site
Chateau-d'Oex, Canton of Vaud, Switzerland
Research Site
Clarens, Canton of Vaud, Switzerland
Research Site
Eysins, Canton of Vaud, Switzerland
Research Site
Lausanne, Canton of Vaud, Switzerland
Research Site
Nyon, Canton of Vaud, Switzerland
Research Site
Prilly, Canton of Vaud, Switzerland
Research Site
Renens VD, Canton of Vaud, Switzerland
Research Site
Salavaux, Canton of Vaud, Switzerland
Research Site
St-Legier, Canton of Vaud, Switzerland
Research Site
Vevey, Canton of Vaud, Switzerland
Research Site
Bassersdorf, Canton of Zurich, Switzerland
Research Site
Egg, Canton of Zurich, Switzerland
Research Site
Winterthur, Canton of Zurich, Switzerland
Research Site
Ascona, Canton Ticino, Switzerland
Research Site
Locarno, Canton Ticino, Switzerland
Research Site
Lugano, Canton Ticino, Switzerland
Research Site
Viganello, Canton Ticino, Switzerland
Research Site
Chur, Kanton Graubünden, Switzerland
Research Site
Ilanz, Kanton Graubünden, Switzerland
Research Site
Samedan, Kanton Graubünden, Switzerland
Research Site
Kreuzlingen, Thurgau, Switzerland
Research Site
Ardon, Valais, Switzerland
Research Site
Evionnaz, Valais, Switzerland
Research Site
Savièse, Valais, Switzerland
Research Site
Sierre, Valais, Switzerland
Research Site
Sion, Valais, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
January 23, 2009
First Posted
January 26, 2009
Study Start
December 1, 2008
Study Completion
August 1, 2009
Last Updated
August 18, 2010
Record last verified: 2010-08